Literature DB >> 28331426

Environmental Distribution and Drug Susceptibility of Achromobacter Xylosoxidans Isolated from Outdoor and Indoor Environments.

Sachiko Nakamoto1, Misaki Sakamoto1, Kana Sugimura1, Yuki Honmura1, Yuki Yamamoto1, Natsumi Goda1, Hiroo Tamaki1, Naoto Burioka1.   

Abstract

Achromobacter xylosoxidans is an environmental bacterium with multi-drug resistance. We isolated Achromobacter xylosoxidans and investigated its susceptibility to 13 drugs. Seventy-eight water samples were collected from rivers and ponds, and 11 samples were swabbed from residential sinks and baths. Nine strains of Achromobacter xylosoxidans were isolated from the 89 samples. Five strains, including 2 that were sampled from residential homes, showed high resistance to multiple aminoglycosides. This indicated that Achromobacter xylosoxidans is widely distributed in various outdoor and indoor environments. Moreover, since these highly resistant bacteria were present in indoor environments, caution should be taken for elderly people living at home. Furthermore, a careful assessment should be made for diagnosing and treating compromised hosts.

Entities:  

Keywords:  Achromobacter xylosoxidans; environmental distribution; environmental resident bacterium; multi-drug resistance; opportunistic infection

Year:  2017        PMID: 28331426      PMCID: PMC5355849     

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  6 in total

1.  In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents.

Authors:  Y Glupczynski; W Hansen; J Freney; E Yourassowsky
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

2.  Achromobacter xylosoxidans n. sp. from human ear discharge.

Authors:  E Yabuuchi; A Oyama
Journal:  Jpn J Microbiol       Date:  1971-09

3.  Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients.

Authors:  Lixia Liu; Tom Coenye; Jane L Burns; Paul W Whitby; Terrence L Stull; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

4.  Properties of Achromobacter xylosoxidans highly resistant to aminoglycoside antibiotics.

Authors:  Sachiko Nakamoto; Natsumi Goda; Tatsuya Hayabuchi; Hiroo Tamaki; Ayami Ishida; Ayaka Suzuki; Kaori Nakano; Shoko Yui; Yuto Katsumata; Yuki Yamagami; Naoto Burioka; Hiroki Chikumi; Eiji Shimizu
Journal:  Jpn J Antibiot       Date:  2016-04

5.  Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.

Authors:  Lucie Amoureux; Julien Bador; Sakina Fardeheb; Cédric Mabille; Charlyne Couchot; Clémence Massip; Anne-Lise Salignon; Guillaume Berlie; Véronique Varin; Catherine Neuwirth
Journal:  Appl Environ Microbiol       Date:  2013-09-13       Impact factor: 4.792

6.  Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes.

Authors:  Tim Holm Jakobsen; Martin Asser Hansen; Peter Østrup Jensen; Lars Hansen; Leise Riber; April Cockburn; Mette Kolpen; Christine Rønne Hansen; Winnie Ridderberg; Steffen Eickhardt; Marlene Hansen; Peter Kerpedjiev; Morten Alhede; Klaus Qvortrup; Mette Burmølle; Claus Moser; Michael Kühl; Oana Ciofu; Michael Givskov; Søren J Sørensen; Niels Høiby; Thomas Bjarnsholt
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

  6 in total
  7 in total

1.  Chronic Airway Colonization by Achromobacter xylosoxidans in Cystic Fibrosis Patients Is Not Sustained by Their Domestic Environment.

Authors:  Chloé Dupont; Estelle Jumas-Bilak; Clara Doisy; Fabien Aujoulat; Raphaël Chiron; Hélène Marchandin
Journal:  Appl Environ Microbiol       Date:  2018-11-15       Impact factor: 4.792

2.  Case Report: Septic Pericarditis With Achromobacter xyloxidans in an Immunosuppressed Dog.

Authors:  Kristina M Pascutti; Jacqueline K Dolan; Lauren T Porter; Shir Gilor; Autumn N Harris
Journal:  Front Vet Sci       Date:  2022-05-18

3.  Duplex real-time PCR assay for the simultaneous detection of Achromobacter xylosoxidans and Achromobacter spp.

Authors:  Erin P Price; Valentina Soler Arango; Timothy J Kidd; Tamieka A Fraser; Thuy-Khanh Nguyen; Scott C Bell; Derek S Sarovich
Journal:  Microb Genom       Date:  2020-07-15

4.  Achromobacter xylosoxidans bacteremia: clinical and microbiological features in a 10-year case series.

Authors:  E Pérez Barragán; J Sandino Pérez; L Corbella; M A Orellana; M Fernández-Ruiz
Journal:  Rev Esp Quimioter       Date:  2018-05-23       Impact factor: 1.553

5.  One-stage revision arthroplasty in a patient with ochronotic arthropathy accompanied by joint infection: A case report.

Authors:  Xiao-Chao Wang; Xiao-Min Zhang; Wan-Ling Cai; Zhen Li; Chao Ma; Yi-Hai Liu; Qi-Lian He; Tian-Sheng Yan; Xue-Wei Cao
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

6.  Draft Genome Sequence of an Unusually Multidrug-Resistant Strain of Achromobacter xylosoxidans from a Blood Isolate.

Authors:  Hosoon Choi; Chetan Jinadatha; Piyali Chatterjee; Yonhui Allton; Dhammika H Navarathna
Journal:  Microbiol Resour Announc       Date:  2020-05-28

7.  Detection of Legionella species, the influence of precipitation on the amount of Legionella DNA, and bacterial microbiome in aerosols from outdoor sites near asphalt roads in Toyama Prefecture, Japan.

Authors:  Jun-Ichi Kanatani; Masanori Watahiki; Keiko Kimata; Tomoko Kato; Kaoru Uchida; Fumiaki Kura; Junko Amemura-Maekawa; Junko Isobe
Journal:  BMC Microbiol       Date:  2021-07-17       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.